Alzheimer's Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Alzheimer's Disease stocks.

Alzheimer's Disease Stocks Recent News

Date Stock Title
Jun 15 LLY Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Jun 15 LLY U.S. drug shortages worsen to reach a decade high: report
Jun 15 LLY Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Jun 15 LLY 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Jun 14 LLY Employee benefits survey finds marked increase in GLP-1 coverage
Jun 14 LLY Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo
Jun 14 PFE Pfizer stock traded in the red for seven straight days
Jun 14 LLY Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Jun 14 LLY Eli Lilly unveils new manufacturing plant for GLP-1 pens
Jun 14 LGND Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Jun 14 LGND Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Jun 14 LLY June consumer sentiment disappoints, Tesla short-selling: Catalysts
Jun 14 LLY Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
Jun 14 LGND What Makes Ligand (LGND) a New Strong Buy Stock
Jun 14 LLY Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
Jun 14 LLY Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Jun 14 BIIB Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Jun 14 BIIB The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Jun 14 LLY The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Jun 14 PFE CDC 'preparing for the possibility' bird flu could spread more easily
Alzheimer's Disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD; however, evidence to support these recommendations is not strong. There are no medications or supplements that have been shown to decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programmes may be beneficial with respect to activities of daily living and can potentially improve outcomes. Behavioural problems or psychosis due to dementia are often treated with antipsychotics, but this is not usually recommended, as there is little benefit with an increased risk of early death.In 2015, there were approximately 29.8 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2015, dementia resulted in about 1.9 million deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.

Browse All Tags